1. Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivo. Issue 9 (13th May 2022) Authors: Wymann, Sandra; Mischnik, Marcel; Leong, David; Ghosh, Subhajit; Tan, Xiahui; Cao, Helen; Kuehnemuth, Benjamin; Powers, Glenn A.; Halder, Partho; de Souza, Mitchell J.; James, Hannah S.; Tomasetig, Vesna; Lind, Holger; Rossato, Paolo; Owczarek, Catherine M.; Ow, Saw Yen; Dower, Steven K.; Baz Mor... Journal: Biochemical journal Issue: Volume 479:Issue 9(2022) Page Start: 1007 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗